PATENT CLAIM ANALYSIS

Application Number: 15971017
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "183000"]

Abstract:
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Claim (Index 26):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein each R B  is independently selected from halo, C 1-6  alkyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 3-6  cycloalkyl, phenyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, CN, OR a2 , C(O)R b2 , C(O)NR c2 R d2 , C(O)OR a2 , NR c2 R d2 , NR c2 C(O)R b2 , and NR c2 C(O)OR a2 ; wherein said C 1-6  alkyl, C 2-6  alkynyl, C 3-6  cycloalkyl, phenyl, 5-6 membered heteroaryl, and 4-7 membered heterocycloalkyl are each optionally substituted with 1, 2, 3, or 4 substituents independently selected from R 12 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.13793
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15469975', '15234690', '15624850', '15247499', '15151259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8421193741481917
- 35 USC 102 Novelty (BERT): 0.6330850038956265
- Combined Prediction Score: 0.8212159371229353
- Mean Citation Score: 531.0717219999998
- Max Citation Score: 638.51373
- Similarity Product: 554.5607025417655

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test